M
Mariantonia Logozzi
Researcher at Istituto Superiore di Sanità
Publications - 76
Citations - 7915
Mariantonia Logozzi is an academic researcher from Istituto Superiore di Sanità. The author has contributed to research in topics: Microvesicles & Exosome. The author has an hindex of 34, co-authored 72 publications receiving 6633 citations. Previous affiliations of Mariantonia Logozzi include New York Medical College.
Papers
More filters
Journal ArticleDOI
Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
Isabella Parolini,Cristina Federici,Carla Raggi,Luana Lugini,Simonetta Palleschi,Angelo De Milito,Carolina Coscia,Elisabetta Iessi,Mariantonia Logozzi,Agnese Molinari,Marisa Colone,Massimo Tatti,Massimo Sargiacomo,Stefano Fais +13 more
TL;DR: The results of this study provide the evidence that exosomes may be used as a delivery system for paracrine diffusion of tumor malignancy, in turn supporting the importance of both exosome and tumor pH as key targets for future anti-cancer strategies.
Journal ArticleDOI
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
Mariantonia Logozzi,Angelo De Milito,Luana Lugini,Martina Borghi,Luana Calabrò,Massimo Spada,Maurizio Perdicchio,Maria Marino,Cristina Federici,Elisabetta Iessi,Daria Brambilla,Giulietta Venturi,Francesco Lozupone,Mario Santinami,Veronica Huber,Michele Maio,Licia Rivoltini,Stefano Fais +17 more
TL;DR: The results suggest that the Exotest for detection of plasma exosomes carrying tumor-associated antigens may represent a novel tool for clinical management of cancer patients.
Journal ArticleDOI
Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice
Stefano M. Santini,Caterina Lapenta,Mariantonia Logozzi,Stefania Parlato,Massimo Spada,Tiziana Di Pucchio,Filippo Belardelli +6 more
TL;DR: The results provide a rationale for using type I IFNs as vaccine adjuvants and support the concept that a natural alliance between these cytokines and monocytes/DCs represents an important early mechanism for connecting innate and adaptive immunity.
Journal ArticleDOI
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Francesca Luciani,Massimo Spada,Angelo De Milito,Agnese Molinari,Licia Rivoltini,Annalisa Montinaro,Manuela Marra,Luana Lugini,Mariantonia Logozzi,Francesco Lozupone,Cristina Federici,Elisabetta Iessi,Giorgio Parmiani,Giuseppe Arancia,Filippo Belardelli,Stefano Fais +15 more
TL;DR: The results open new possibilities for the treatment of drug-resistant tumors through combination strategies based on the use of well-tolerated pH modulators such as PPIs.
Journal ArticleDOI
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
Stefano Fais,Lorraine O'Driscoll,Francesc E. Borràs,Edit I. Buzás,Giovanni Camussi,Francesco Cappello,Joana Carvalho,Anabela Cordeiro da Silva,Hernando A. del Portillo,Samir El Andaloussi,Samir El Andaloussi,Tanja Ficko Trček,Roberto Furlan,An Hendrix,Ihsan Gursel,Veronika Kralj-Iglič,Bertrand Kaeffer,Maja Kosanović,Marilena E. Lekka,Georg Lipps,Mariantonia Logozzi,Antonio Marcilla,Marei Sammar,Alicia Llorente,Irina Nazarenko,Carla Oliveira,Gabriella Pocsfalvi,Lawrence Rajendran,Graça Raposo,Eva Rohde,Pia Siljander,Guillaume van Niel,M. Helena Vasconcelos,María Yáñez-Mó,Marjo Yliperttula,Natasa Zarovni,Apolonija Bedina Zavec,Bernd Giebel +37 more
TL;DR: The high potential of nanosized EVs for both diagnostic and therapeutic areas of nanomedicine, as demonstrated by the European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD), is demonstrated.